Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Do we really want "equality of access"?
On of the "most taxing issues" addressed by last
month's report of the Independent Inquiries into Paediatric Cardiac
Services at the Royal Brompton Hospital and Harefield
Hospital
1 2
was the allegation that children with Down's
syndrome were discriminated against at the Royal Brompton Hospital. It
was alleged (but not proved) that children were inappropriately
"steered away" from surgery for heart defects because they had
Down's syndrome. The report recommends that: "The Trust's policies
confirm clearly that people with a disability are entitled to, and will
be accorded . . . the same rights of access to services
as those without a disability; and that consultants should take the
lead in implementing policies and influencing attitudes regarding
equality of access." Similarly, a guiding principle in the report's
model guidance to avoid discrimination is that: "Access to services,
and priority for treatment, should be determined only on the basis of
clinical need." The principle of equality of access is thus equal
treatment for equal need.
Equality of access is uncontroversial when there are resources to treat
everyone. It would then be unfair discrimination to deny a child
lifesaving surgery because she had a disability Equality of access is problematic, however, when resources are scarce.
The report admits there were serious shortcomings in resources for
cardiac surgery in the 1980s and early 1990s, though it is difficult to
judge how relevant these were to treatment decisions. However, resource
considerations are critical when evaluating any principle of equality
of access.
Consider the current situation over heart transplantation in children
(not performed at the Brompton). Some children with Down's syndrome
need a heart transplant. Should they be placed on the waiting list? A
Channel 4 edition of Inside Out reported one case of a
child who was denied heart-lung transplantation because of her Down's
syndrome.4 Her mother believed the medical argument was:
"There are so few organs they're not going to waste one on my child."
In Australia about a third of children waiting for heart transplants
die before transplantation because of the scarcity of hearts. With a
severe shortage of hearts, transplanting a child with Down's syndrome
implies that a child without Down's syndrome will die who would
otherwise have received a transplant.
Should quality of life be a relevant factor in deciding how to allocate
scarce resources? The Brompton report was critical of reference to
quality of life evaluations and "value judgements Yet we do appeal to quality of life in deciding how much
benefit people derive from scarce resources. For example, people with
brain injury or dementia resulting in a severely impaired cognitive
state (such that they cannot interact socially with other people) may
be denied transplantation, not because it is against their interests,
but because the scarce organs would do more good if directed to a
person without such impairments. Quality of life is taken
into account when allocating organs, as when hearts are matched to
recipients of a similar size to provide the best functional result.
If we appeal to equality of access and fail to consider the magnitude
of the benefit a person expects to derive from treatment, absurd
consequences follow. Equality of access requires that we ignore not
just quality of life but also its length. Imagine George is 1 year old
and has a metabolic abnormality. He will die in one year, but without a
transplant he will die in the next few weeks. John is also 1 year old
and has cardiomyopathy and could expect up to 20 years of life if he
receives a heart transplant. According to equality of access, both need
a heart transplant to live, so both should have an equal chance. This
seems absurd. We should give priority to John.
The idea of equality of access is that each of us has a life of equal
value, and arbitrary factors like disability should not be considered
in determining eligibility for treatment. John Harris claims that each
rational person wants for himself or herself at least three
things from health care: (a) the maximum possible life
expectancy; (b) the best quality of life; and (c)
the best opportunity or chance of getting both.5
Treating people as equals involves giving equal weight to each
person's own claim. As Harris recognised, a principle of equality
cannot be selectively invoked only by those with disability but also
applies to those who happen to have poor prognoses or diseases that are
expensive to treat.6
Equality of access thus requires that we ignore the probability of
survival. This is inconsistent with accepted practice. Every day older
women in Britain are denied in vitro fertilisation because they
have a lower chance of a successful outcome. We do not follow the
principle that "anything goes" irrespective of likelihood of
success. In 1995 Jaymee Bowen (Child B) was denied a second bone marrow
transplant for leukaemia because it would cost £75 000 and there was
little chance of success. Her father took Cambridge Health Authority to
court. Sir Thomas Bingham, Master of the Rolls, appealed to a principle
of maximising benefit when he rejected the father's appeal:
"Difficult and agonizing judgments have to be made as to how a
limited budget is best allocated to the maximum advantage of the
maximum number of patients."7 Indeed, the General
Medical Council has stated that "the clinical team in determining
priorities and the utilisation of the resources made available to them
by the NHS is entitled to take into account the likely success of the
treatment proposed."8
Under conditions of sufficient resources, equality of access is
ethically mandated. However, under conditions of insufficient resources
to treat everyone (and these will always be with us), unthinking
application of the principle of equality means fewer people will live,
and those who do live will live shorter and worse quality lives. It
also rejects a cost effectiveness approach to maximising benefits to
different but mutually exclusive populations of patients.
We should face reality: quality and length of life and probability of
benefit (and cost of treatment) are relevant in determining who should receive treatment. Severe disability in some circumstances should disqualify a person from access to scarce resources. With the
current shortage of donor hearts, it would be wrong to transplant a
barely conscious child with severe intellectual disability or a child
with congenital myotonia dystrophica dependent on a ventilator.
It is probably unlawful to place lower priority on children with
Down's syndrome and other disabilities who need heart transplants. But
is it unethical? Doctors cannot and should not be involved in fine
grained evaluations of the worthiness of different lives,9 and a tolerant and affluent society would strive to provide equality of
access to everyone for as many interventions as possible. Whether disability such as Down's syndrome should be considered relevant in
allocating a scarce resource turns on how much the disability associated with it detracts from a good life.10
Down's syndrome is associated with intellectual disability,
infertility, reduced opportunities for independent living and employment, shorter life, and early onset Alzheimer's disease. These
all make those lives worse. But considerable variation exists in the
quality of life of people with disability, particularly those with
Down's syndrome. A person with intellectual disability can have a
happy and worthwhile life. This is why it is essential to judge every
case for heart transplantation on its merits, assessing all the
factors, but including the likelihood of a good outcome in any
particular case.
But there are better alternatives. We could increase the amount we
spend on health. In the case of transplantation we could change our
selfish and unreflective attitudes to organ donation by moving to an
opt out system for organ donation. One terrible constraint that forces
us to decide between people would then be removed.
Murdoch Children's Research Institute, Royal Children's
Hospital, Melbourne, Victoria 3052, Australia
unless one believed
her disability was so severe that it was not in her interests to
continue to live. Until a few years ago some doctors did believe that
about Down's syndrome.3 Such a view is now roundly
rejected. One of the report's major points is that prolonging treatment is in the interests of a person with Down's syndrome.
for example
related to factors such as limited lifespan, inability to get the most
out of life, or not being a burden upon others or upon society."
Equality of access urges us to ignore such considerations. So does the
law. The European Convention on Human Rights 1950 states:
"Everyone's right to life shall be protected by law
. . . No one shall be deprived of his right to
life intentionally" and "The enjoyment of the rights and freedoms
set forth in this Convention shall be secured without discrimination on
any ground such as sex, race, colour . . . or
other status." Denying children with Down's syndrome access to
transplants is therefore probably unlawful discrimination.
JS is employed by the Murdoch Children's Research Institute, which conducts genetic research relevant to understanding the causes of Down's syndrome.
| 1. | www.rbh.nthames.nhs.uk/ |
| 2. |
Kmietowicz Z.
Down's children received "less favourable" hospital treatment.
BMJ
2001;
322:
815 |
| 3. | Molenaar JC. The legal investigation of a decision not to operate on an infant with Down's syndrome and duodenal atresia. Bioethics 1992; 6: 35-40[Medline]. |
| 4. |
Sommerville A.
A view from the back of the queue.
BMJ
1996;
313:
499 |
| 5. | Harris J. What is the good of health care? Bioethics 1996; 10: 269-291[Medline]. |
| 6. | Harris J. QALYfying the value of life. J Med Ethics 1987; 13: 117-123[Abstract]. |
| 7. | R v Cambridge Health Authority, ex p B [1995] 2 All ER 129, 133 (CA). |
| 8. | GMC. Priorities and choices. London: GMC, 2000. |
| 9. | Savulescu J. Consequentialism, reasons, value and justice. Bioethics 1998; 12: 212-235[CrossRef][Medline]. |
| 10. | Savulescu J. Desire-based and value-based normative reasons. Bioethics 1999; 13: 405-413[Medline]. |
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.